Skip to main content
Livermore
Livermore
ZHEN

Cardiff Oncology, Inc.

CRDF
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001213037

In the last 90 days, Cardiff Oncology, Inc. insiders filed 2 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q2 2026, worth $24.2M in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Cardiff Oncology, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
53
−2 vs. Q1 2023
Shares held
5.99M
−1.06M (−15.0%) vs. Q1 2023
Total value
$8.81M
−$2.83M (−24.3%) vs. Q1 2023
New holders
3
12 more added
Sold out
5
9 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CRDF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 53 institutions
Q1 2021: 73 institutionsQ2 2021: 90 institutionsQ3 2021: 94 institutionsQ4 2021: 87 institutionsQ1 2022: 91 institutionsQ2 2022: 67 institutionsQ3 2022: 58 institutionsQ4 2022: 60 institutionsQ1 2023: 55 institutionsQ2 2023: 53 institutionsQ3 2023: 56 institutionsQ4 2023: 55 institutionsQ1 2024: 77 institutionsQ2 2024: 90 institutionsQ3 2024: 83 institutionsQ4 2024: 117 institutionsQ1 2025: 116 institutionsQ2 2025: 115 institutionsQ3 2025: 112 institutionsQ4 2025: 110 institutionsQ1 2026: 117 institutionsQ2 2026: 104 institutions
Value heldQ2 2023: $8.81M
Q1 2021: $223.0MQ2 2021: $176.4MQ3 2021: $140.7MQ4 2021: $132.1MQ1 2022: $41.0MQ2 2022: $19.6MQ3 2022: $12.2MQ4 2022: $10.8MQ1 2023: $11.6MQ2 2023: $8.81MQ3 2023: $7.58MQ4 2023: $7.84MQ1 2024: $45.8MQ2 2024: $29.1MQ3 2024: $34.1MQ4 2024: $121.9MQ1 2025: $101.6MQ2 2025: $90.3MQ3 2025: $51.9MQ4 2025: $76.6MQ1 2026: $39.7MQ2 2026: $24.2M
Institutions holding CRDF and their total value by quarter
QuarterHoldersValue
Q2 2026104$24.2M
Q1 2026117$39.7M
Q4 2025110$76.6M
Q3 2025112$51.9M
Q2 2025115$90.3M
Q1 2025116$101.6M
Q4 2024117$121.9M
Q3 202483$34.1M
Q2 202490$29.1M
Q1 202477$45.8M
Q4 202355$7.84M
Q3 202356$7.58M
Q2 202353$8.81M
Q1 202355$11.6M
Q4 202260$10.8M
Q3 202258$12.2M
Q2 202267$19.6M
Q1 202291$41.0M
Q4 202187$132.1M
Q3 202194$140.7M
Q2 202190$176.4M
Q1 202173$223.0M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Cardiff Oncology, Inc.; share changes are against Q1 2023.

Institutions holding CRDF in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Front Row Advisors LLC2$00.00%00.0%Unchanged
BerganKDV Wealth Management, LLC1$20.00%+1New
Sofos Investments, Inc.1$20.00%+1New
JPMorgan Chase & Co26$380.00%00.0%Unchanged
Northwestern Mutual Wealth Management Co48$710.00%00.0%Unchanged
GWM Advisors LLC81$1190.00%00.0%Unchanged
Allworth Financial LP100$1470.00%00.0%Unchanged
US Bancorp109$1600.00%00.0%Unchanged
Newbridge Financial Services Group, Inc.115$1690.00%00.0%Unchanged
NewSquare Capital LLC125$1840.00%00.0%Unchanged
Fifth Third Bancorp200$2940.00%+200New
Eagle Bay Advisors LLC339$4980.00%00.0%Unchanged
Global Retirement Partners, LLC350$5150.00%00.0%Unchanged
The PNC Financial Services Group, Inc.1,520$2.23K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.1,565$2.30K0.00%00.0%Unchanged
FMR LLC2,540$3.73K0.00%−4,805−65.4%Reduced
UBS Group AG3,814$5.61K0.00%−11,876−75.7%Reduced
America First Investment Advisors, LLC4,000$5.88K0.00%00.0%Unchanged
Wells Fargo & Company7,799$11.5K0.00%+12+0.2%Added
Callan Capital, LLC13,587$20.0K0.00%00.0%Unchanged
Gladstone Institutional Advisory LLC14,000$20.6K0.00%00.0%Unchanged
Bank of New York Mellon Corp14,350$21.1K0.00%00.0%Unchanged
HighTower Advisors, LLC15,333$22.0K0.00%00.0%Unchanged
Tortoise Investment Management, LLC15,000$22.1K0.00%00.0%Unchanged
Morgan Stanley15,713$23.1K0.00%−188,135−92.3%Reduced
FinDec Wealth Services, Inc.16,000$23.5K0.02%00.0%Unchanged
Charles Schwab Investment Management Inc16,399$24.1K0.00%00.0%Unchanged
Denver Wealth Management, Inc.18,235$26.8K0.02%00.0%Unchanged
Atom Investors LP18,298$26.9K0.01%00.0%Unchanged
Royal Bank of Canada19,299$28.0K0.00%+317+1.7%Added
Group One Trading, L.P.27,976$41.1K0.00%+5,842+26.4%Added
Dimensional Fund Advisors LP31,299$46.0K0.00%00.0%Unchanged
Price T Rowe Associates Inc36,500$54.0K0.00%00.0%Unchanged
Elkhorn Partners Limited Partnership47,000$69.0K0.04%+12,000+34.3%Added
Millennium Management LLC48,739$71.6K0.00%−55,203−53.1%Reduced
Bank of America Corp49,788$73.2K0.00%−30,130−37.7%Reduced
Capstone Investment Advisors, LLC51,190$75.2K0.00%00.0%Unchanged
Creative Planning57,750$84.9K0.00%+33,250+135.7%Added
Northern Trust Corp72,386$106.4K0.00%+1,963+2.8%Added
Citadel Advisors LLC86,123$126.6K0.00%+79,116+1,129.1%Added
Two Sigma Investments, LP93,232$137.1K0.00%+63,232+210.8%Added
Susquehanna International Group, LLP94,504$138.9K0.00%−97,999−50.9%Reduced
Jacobs Levy Equity Management, Inc97,053$142.7K0.00%+55,576+134.0%Added
Blair William & Co130,500$191.8K0.00%00.0%Unchanged
State Street Corp139,945$205.7K0.00%00.0%Unchanged
Assenagon Asset Management S.A.142,428$209.4K0.00%−252,566−63.9%Reduced
Two Sigma Advisers, LP172,800$254.0K0.00%+29,300+20.4%Added
Gsa Capital Partners LLP296,677$436.0K0.04%+15,998+5.7%Added
Renaissance Technologies LLC311,290$458.0K0.00%−20,018−6.0%Reduced
Geode Capital Management, LLC381,150$560.3K0.00%−32,352−7.8%Reduced
Laurion Capital Management LP722,100$1.06M0.05%00.0%Unchanged
BlackRock Inc.760,272$1.12M0.00%+2,454+0.3%Added
Vanguard Group Inc1,942,918$2.86M0.00%00.0%Unchanged
Citigroup Inc0$00.00%−651,161−100.0%Sold out
Belpointe Asset Management LLC0$00.00%−11,454−100.0%Sold out
Tower Research Capital LLC (TRC)0$00.00%−392−100.0%Sold out
CWM, LLC0$00.00%−850−100.0%Sold out
Larson Financial Group LLC0$00.00%−150−100.0%Sold out